jenny mollen glp 1 says weight loss medication use preceded frightening medical emergency Jenny Mollen details 'harrowing' experience

As a consequence, levels of adherence are lower than for people with diabetes, as demonstrated by another study that applied the same metric of adherence to people using GLP-1s to treat obesity: 40.1% for Ozempic (semaglutide, Novo Nordisk), 31.5% for weekly injectable Wegovy and just 15% for daily injectable Saxenda (liraglutide, Novo Nordisk).10 This suggests that greater expectation management is required to maintain users faith in the value and purpose of what they are doing

But the magnitude is not comparable

Medical supervision, regular health monitoring, and strict adherence to recommended dosage guidelines ensure users maximize benefits while minimizing potential risks

Authors W.H

Contact GLP-1 RA attorney Sara Couch or Jonathan Orent

Use portion control strategies, such as measuring oil when cooking (1 tablespoon is about 120 calories) or limiting nuts to a small handful (about 28g)